Use of Genetically Modified Mesenchymal Stem Cells to Treat Neurodegenerative Diseases

The transplantation of mesenchymal stem cells (MSCs) for treating neurodegenerative disorders has received growing attention recently because these cells are readily available, easily expanded in culture, and when transplanted, survive for relatively long periods of time. Given that such transplants...

Descripción completa

Detalles Bibliográficos
Autores principales: Wyse, Robert D., Dunbar, Gary L., Rossignol, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International (MDPI) 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958818/
https://www.ncbi.nlm.nih.gov/pubmed/24463293
http://dx.doi.org/10.3390/ijms15021719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3958818/
https://www.ncbi.nlm.nih.gov/pubmed/24463293
http://dx.doi.org/10.3390/ijms15021719

Ejemplares similares